![Arshad Siddiqui](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Arshad Siddiqui
Chief Executive Officer at Paraza Pharma, Inc.
Profile
Arshad Siddiqui is the founder of Paraza Pharma, Inc. which he founded in 2011 and where he holds the title of President & Chief Executive Officer.
He is currently the Director at Egenix, Inc. where he started in 2013.
Dr. Siddiqui holds a doctorate degree from The University of Waterloo.
Arshad Siddiqui active positions
Companies | Position | Start |
---|---|---|
Egenix, Inc.
![]() Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Director/Board Member | 20/05/2013 |
Paraza Pharma, Inc. | Chief Executive Officer | 31/12/2010 |
Training of Arshad Siddiqui
The University of Waterloo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Egenix, Inc.
![]() Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Health Technology |
Paraza Pharma, Inc. |
- Stock Market
- Insiders
- Arshad Siddiqui